|
Immunotherapy-treated melanoma brain metastases within the French national cohort, MelBase. |
|
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
Research Funding - Roche/Genentech (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche/Genentech |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Roche/Genentech |
Research Funding - Roche (Inst) |
|
|
No Relationships to Disclose |
|
|
Honoraria - Abbvie; Bristol-Myers Squibb; Pfizer |
Consulting or Advisory Role - Abbvie; Pfizer |
Other Relationship - Novartis (I); Roche (I) |
|
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche |
|
|
Consulting or Advisory Role - Roche |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Novartis; Roche |
Research Funding - Roche (Inst) |
Travel, Accommodations, Expenses - MSD; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Roche |
Travel, Accommodations, Expenses - Abbvie; Janssen-Cilag; Novartis |
|
|
Honoraria - Bristol-Myers Squibb; Novartis; Roche/Genentech |
Consulting or Advisory Role - Bristol-Myers Squibb; Novartis; Roche |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche |
|
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Novartis; Roche |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; MSD; Novartis; Roche/Genentech |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Novartis; Roche |
Research Funding - Roche (Inst) |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Novartis; Roche |